IBD Registry Symposium at BSG
A very successful session was held at the BSG Meeting with a broad Registry update from Fraser Cummings, a patient perspective from David Barker including a video message from Carrie Grant, an introduction to the new Data Visualisation charts on the Registry Web Tool from Mark Allan and interim findings from the Anaemia Service Evaluation Study being conducted using the Registry Web Tool.
Perhaps the most eagerly awaited presentation was from Keith Bodger providing an insight into the analysis and reporting that is now becoming possible by combining the Registry and HES data. Keith also presented a summary form the recent survey on how best to present Registry and HES data back to sites and thanked everyone for their responses.
The presentations from the Registry session will be made available on the IBD Registry Website over the next few weeks. www.ibdregistry.org.uk
CALDICOTT GUARDIAN OPPORTUNITY
The Registry has a vacancy for a Caldicott Guardian to support all Information Governance aspects of the project. Please contact [email protected] for more information.
IBD REGISTRY 2017 ROADSHOWS
The 2017 Roadshow has now visited 6 cities in England and Wales, reaching over 123 IBD doctors, nurses, audit leads and other team members from over 40 trusts or health boards. With a focus on practical information and action planning, the meetings provided a chance to think and plan away from the hospital, as well as a forum to share experiences and tips. The most common challenges and proposed solutions are below:
|Data entry||Pick a sub group
Plan your approach
Apply for a grant
|How to manage the consent process||Consent by post
During infusion clinic
|IT barriers||Enlist support of patient panel
|How to get the team on board||Meet with team & show them the data
Feed back to MDT
Remember Rome wasn’t built in a day
|Understanding more about the Registry data entry options||Contact [email protected]
Request a demo from PMS suppliers (e.g. CIMS, Emis)
Speak to users of different systems
A meeting is planned for Scotland later in the year, and you can register your interest at http://ibdrroadshow2017.eventreference.com/
QUARTERLY DATA SUBMISSION
Thank you to everyone who uploaded data to NHS Digital at the end of June. The next data submission deadlines are 30th September and 29th December. If you need any help at all in preparing for this, or if you have not yet registered with NHS Digital, please email [email protected]. Once you are registered with NHS Digital, please make your first data submission as soon as possible to test the process and familiarize yourself. Please do not wait for the deadline date to do this as it is difficult for the Registry and CIMS Support services to resolve any technical issues at the last minute.
You will not cause any problems by uploading data more frequently. The data deadline is the point at which NHS Digital will create a new extract of the complete dataset, pseudonymise it and provide it to the Registry for analysis.
With our thanks for your continued engagement in the IBD Registry,
Dr Stuart Bloom,
IBD Registry Chair
Dr Fraser Cummings,
IBD Registry Clinical Lead
Find out more about…
The IBD Registry is recruiting three important posts to help its next phase of growth as one of the largest IBD registries in Europe. We are recruiting a Data Analytics Manager, a Projects and Operations Manager and a Data Analyst/ Developer. The roles will support...
The IBD Registry has published its first Annual Report on the Use of Biologics for Inflammatory Bowel Diseases for the year 2018-19. The report includes the cumulative results to January 2019 from April 2016 when the Registry assumed the role of supporting the National Audit of Biological Therapies from the Royal College of Physicians.
A £5m grant has been awarded by Health Data Research UK (HDR UK) to establish a health data research hub for inflammatory bowel disease (IBD). The IBD hub, to be known as Gut Reaction – The Health Data Research Hub for Inflammatory Bowel Disease, will bring together...
The IBD Registry is inviting UK IBD clinical centres to participate in a post-marketing safety study of patients using Zessly (infliximab), a biosimilar available for the treatment of Inflammatory Bowel Disease (IBD). This study is facilitated by the Registry on...
The IBD Registry is delighted a presentation prepared by the Registry’s Analytics Hub at the University of Liverpool featured in the British Society of Gastroenterology Annual Meeting in Glasgow. The Audit of biological therapy for IBD - Shawihdi et al Poster BSG 2019...